Patents by Inventor Barry S. Ganetzky

Barry S. Ganetzky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10207011
    Abstract: Described herein are methods, systems, and devices for identifying agents and genetic pathways that modulate the effects of traumatic brain injury (TBI) in invertebrate model systems having a brain, e.g., Drosophila or C. elegans.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: February 19, 2019
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Barry S. Ganetzky, David A. Wassarman
  • Publication number: 20140377183
    Abstract: Described herein are methods, systems, and devices for identifying agents and genetic pathways that modulate the effects of traumatic brain injury (TBI) in invertebrate model systems having a brain, e.g., Drosophila or C. elegans.
    Type: Application
    Filed: June 25, 2014
    Publication date: December 25, 2014
    Inventors: Barry S. Ganetzky, David A. Wassarman
  • Patent number: 7060249
    Abstract: A method for obtaining a Drosophila neurodegeneration mutant includes the steps of selecting at least one Drosophila mutant having an aberrant phenotype selected from the group consisting of temperature-sensitive paralysis and bang-sensitive paralysis; and screening the at least one selected Drosophila mutant for age-dependent neurodegeneration. Neurodegeneration mutants are obtained in the method and causal mutations are characterized. The neurodegeneration mutants can be used in screening methods to identify putative neuroprotective agents.
    Type: Grant
    Filed: May 22, 2002
    Date of Patent: June 13, 2006
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Barry S. Ganetzky, Michael J. Palladino
  • Publication number: 20030226156
    Abstract: A method for obtaining a Drosophila neurodegeneration mutant includes the steps of selecting at least one Drosophila mutant having an aberrant phenotype selected from the group consisting of temperature-sensitive paralysis and bang-sensitive paralysis; and screening the at least one selected Drosophila mutant for age-dependent neurodegeneration. Neurodegeneration mutants are obtained in the method and causal mutations are characterized. The neurodegeneration mutants can be used in screening methods to identify putative neuroprotective agents.
    Type: Application
    Filed: May 22, 2002
    Publication date: December 4, 2003
    Inventors: Barry S. Ganetzky, Michael J. Palladino
  • Patent number: 6087488
    Abstract: Novel genes in the erg subfamily of potassium channel proteins in humans are described. This family of proteins, and the genes encoding the proteins, are implicated in the development of long Q-T syndrome, a rare, but often fatal, cardiac arrhythmia.
    Type: Grant
    Filed: July 12, 1999
    Date of Patent: July 11, 2000
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Barry S. Ganetzky, Steven A. Titus
  • Patent number: 5986081
    Abstract: Novel genes in the erg subfamily of potassium channel proteins in humans are described. This family of proteins, and the genes encoding the proteins, are implicated in the development of long Q-T syndrome rare, but often fatal, cardiac arrhythmia.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: November 16, 1999
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Barry S. Ganetzky, Steven A. Titus